Skip to main content

Roivant Social Ventures Archives

VUMC to test whether Alzheimer’s drug can ease lupus symptoms

Oct. 6, 2022—Vanderbilt University Medical Center is partnering with Evergreen Therapeutics Inc. to test whether an Alzheimer’s drug, memantine, can improve cognitive symptoms associated with systemic lupus.

Read more


VUMC and Roivant Social Ventures announce collaboration to develop therapies for underserved populations

Jul. 6, 2022—Vanderbilt University Medical Center and Roivant Social Ventures (RSV) this week announced an intention to collaborate in developing therapies for traditionally underserved populations and diseases.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more